ArticleClinical trials (London, England)2022

Commentary: Two approaches to analyze platform trials incorporating non-concurrent controls with a common assumption.

Marta Bofill Roig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.